May 29, 2022 3:29 AM
BACK TO TOP
KSE100
42,861.45
319.74
(0.75%)
ALLSHR
29,257.53
230.68
(0.79%)
KSE30
16,276.12
133.09
(0.82%)
KMI30
69,055.39
597.56
(0.87%)
BKTi
11,870.79
30.79
(0.26%)
OGTi
10,735.28
97.75
(0.92%)
KMIALLSHR
21,000.61
185.67
(0.89%)
UPP9
11,123.70
81.65
(0.74%)
NITPGI
8,929.02
60.71
(0.68%)
NBPPGI
10,613.27
62.17
(0.59%)
MZNPI
8,676.95
62.21
(0.72%)
JSMFI
10,488.56
147.87
(1.43%)
ACI
8,265.60
74.83
(0.91%)
Citi Pharma Ltd.
PHARMACEUTICALS
Rs.31.08
0.02
(0.06%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Fri, May 27, 2022 5:07 PM
REG
FUT
ODL
Open
31.49
High
32.40
Low
31.00
Volume
696,500
CIRCUIT BREAKER
28.73 — 33.39
DAY RANGE
31.00 — 32.40
52-WEEK RANGE
28.00 — 55.06
Ask Price
0.00
Ask Volume
0
Bid Price
31.08
Bid Volume
500
LDCP
31.06
VAR
11.50
HAIRCUT
15.00
P/E Ratio (TTM) **
9.71
1-Year Change *
0.06%
YTD Change *
-13.09%
Last update: Tue, May 24, 2022 2:01 PM
Open
0.00
High
29.77
Low
29.77
Close
29.77
Change
0.00%
LDCP
31.07
Volume
1,880,000
Total Trades
13
CIRCUIT BREAKER
28.74 — 33.40
DAY RANGE
29.77 — 29.77
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Tue, May 17, 2022 11:52 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
31.48
Volume
0
Total Trades
0
CIRCUIT BREAKER
29.12 — 33.84
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Open
31.50
High
32.50
Low
31.10
Close
31.10
Change
0.13%
LDCP
31.06
Volume
2,597
Total Trades
39
CIRCUIT BREAKER
27.95 — 34.17
DAY RANGE
31.10 — 32.50
Ask Price
31.70
Ask Volume
20
Bid Price
31.10
Bid Volume
6
Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

Citi Pharma Limited incorporated as a private limited company in Pakistan under the repealed Companies Ordinance, 1984 on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products.

KEY PEOPLE
Mr. Rizwan SheikhCEO
Mr. Nadeem AmjadChairman
Mr. Muhammad RiazCompany Secretary
ADDRESS

Corporate Office: 588-Q Block, Johar Town, Lahore

WEBSITE

www.citipharma.com.pk

AUDITOR

Aslam Malik & Co. Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
7,100,574.10
Shares
228,461,200
Free Float
79,961,420
Free Float
35.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Apr 28, 2022Transmission of Quarterly Report for the Period Ended March 31, 2022 View   PDF
Apr 20, 2022Financial Results for the 3rd Quarter ended March 31, 2022 View   PDF
Feb 28, 2022Transmission of 2nd Quarter Report for the Period ended December 31, 2021 View   PDF
Feb 22, 2022Financial Results for the 2nd Quarter ended December 31, 2021 View   PDF
Oct 29, 2021Financial Results for the first quarter ended September 30, 2021 View   PDF
Oct 7, 2021Transmission of Annual Report for the year ended June 30, 2021 View   PDF
Sep 30, 2021Financial Results for the year ended June 30, 2021 View   PDF
DateTitleDocument
Apr 12, 2022Board Meeting View   
Feb 11, 2022Board Meeting View   
Dec 29, 2021Resolutions Passed in Annual General Meeting View   PDF
Oct 22, 2021Board Meeting View   
Oct 7, 2021Notice of Annual General Meeting View   PDF
Sep 23, 2021Board Meeting View   
Sep 13, 2021Decisions of Baord Meeting View   PDF
Aug 31, 2021Board Meeting View   
Aug 13, 2021Decisions of the Board Meeting View   PDF
Aug 6, 2021Board Meeting View   
DateTitleDocument
Feb 22, 2022Material Information View   PDF
Feb 18, 2022Material Information View   PDF
Dec 31, 2021Material Information View   
Nov 25, 2021Credit of Final Cash Dividend View   
Nov 22, 2021Material Information View   
Nov 18, 2021Credit of Bonus Share Certificates View   PDF
Nov 1, 2021Transmission of Quarterly Report for the period September 30, 2021 View   PDF
Sep 16, 2021Material Information View   PDF
Aug 6, 2021Change of Director View   
Jul 27, 2021Change of Director View   

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2021202020192018
Sales5,795,4043,527,6252,607,0282,003,334
Profit after Taxation351,768143,41627,804116,866
EPS4.6431.876.1825.97
Q3 2022Q2 2022Q1 2022Q3 2021
Sales2,748,1392,850,2791,990,9531,779,989
Profit after Taxation207,449261,69881,35799,332
EPS0.921.110.410.74
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2021202020192018
Gross Profit Margin (%)13.4712.3912.6913.12
Net Profit Margin (%)6.074.071.075.83
EPS Growth (%)(85.44)415.70(76.20)37.70
PEG(0.09)

Payouts

DateFinancial ResultsDetailsBook Closure
September 30, 2021 9:32 PM30/06/2021(YR) 15% (D) - 10% (B) 21/10/2021 - 28/10/2021

Financial Reports